DiviDrip · ARCT

ARCT — Arcturus Therapeutics Holdings Inc.

ARCT is Arcturus Therapeutics Holdings Inc. (Healthcare) — a non-dividend-paying stock. Trading at $15.82. Market cap: $450M. Capital Quality Rank: 56/100 — Above average.

Stock snapshot

Price$15.82
Market cap$450M
SectorHealthcare
ExchangeNGM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)56 / 100 · Above average
Revenue CAGR (3y)-26.4%
Shareholder buyback yield-1.41%
Altman Z-score zoneGrey

About ARCT

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

Listed2013Employees111HQSan Diego, CASectorHealthcareWebsitearcturusrx.com

Related non-dividend companies

Other non-dividend stocks investors research alongside ARCT. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is ARCT's current stock price?

ARCT (Arcturus Therapeutics Holdings Inc.) is currently trading at $15.82.

Does ARCT pay a dividend?

ARCT (Arcturus Therapeutics Holdings Inc.) does not currently pay a regular dividend.

What is ARCT's Capital Quality Rank?

ARCT has a Capital Quality Rank of 56/100 — Above average. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track ARCT in DiviDrip

Add ARCT to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow